ArticleTranslational vision science & technology2025
Pediatric Fungal Keratitis: Predisposing Factors, Clinical Features, and Outcomes During a 24-Year Study.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the clinical features, antifungal susceptibility patterns, and treatment outcomes of pediatric fungal keratitis (FK) at a tertiary eye center in North China. Methods: A retrospective study of pediatric FK cases diagnosed between July 2000 and October 2023 at Beijing Tongren Hospital, confirmed by fungal culture or microscopy. Data on demographics, predisposing factors, clinical signs, microbiological findings, treatment, and prognosis were analyzed. Results: Eighty-eight pediatric FK cases (66 males, 22 females; mean age 10.8 ± 2.3 years) were collected. Trauma history (35.2%) was primarily from toys and writing tools. Dense infiltrates (100%), feathery margins (69.2%), and multifocal lesions (38.5%) were the common features. Hypopyon was less frequent (15.5%); no endothelial plaques, collar-button lesions, and pigment deposits were observed. Fusarium (43.9%) and Aspergillus (25.8%) were the predominant isolates. Amphotericin B demonstrated both in vitro and clinical efficacy. Treatment duration (median 48.1 days) varied by risk factors (P < 0.001), age (P = 0.013), and fungal type (P = 0.016). Multivariate analysis identified ocular surgery (hazard ratio [HR] = 0.04, P < 0.001) and toddler age (HR = 3.67, P = 0.013) as the strongest predictors of prolonged and faster treatment duration, respectively. Conclusions: Trauma is the leading risk factor of pediatric FK in North China, with Fusarium and Aspergillus being the predominant pathogens. Amphotericin B is the most effective antifungal, and early diagnosis and treatment are critical for improving outcomes. Translational Relevance: This study provides evidence-based data on fungal trends, antifungal susceptibility, and treatment outcomes, guiding optimal drug selection and therapeutic strategies to reduce visual impairment in pediatric FK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.